All Stories

  1. Changing Paradigm for Vertigo/Dizziness Patients: a Retrospective Before-After Study from Tertiary Hospitals in Northwestern China
  2. Activation of Inflammation is Associated with Amyloid-β Accumulation Induced by Chronic Sleep Restriction in Rats
  3. Quantitative Assessment of Finger Movement Profile in a Visual-Motor Task Based on a Tablet Computer: The Application in Parkinson’s Disease
  4. Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Subacute Combined Degeneration: Revealing a Genetic Predisposition
  5. Proline dehydrogenase gene (PRODH) polymorphisms and schizophrenia susceptibility: a meta-analysis
  6. Astragaloside IV rescues MPP+-induced mitochondrial dysfunction through upregulation of methionine sulfoxide reductase A
  7. Amyloid β-Induced Redistribution of Transcriptional Factor EB and Lysosomal Dysfunction in Primary Microglial Cells
  8. Apolipoprotein E genotyping using PCR-GoldMag lateral flow assay and its clinical applications
  9. Dkk1: A promising molecule to connect Alzheimer’s disease and osteoporosis
  10. Association between two α-2-macroglobulin gene polymorphisms and Parkinson's disease: a meta-analysis
  11. Meta-analysis of the association between two neprilysin gene polymorphisms and Alzheimer's disease
  12. EGCG make an internalization of 67Kda laminin receptor in macrophage/microglia
  13. Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease
  14. Epigallocatechin-3-gallate inhibits interleukin-6- and angiotensin II-induced production of C-reactive protein in vascular smooth muscle cells
  15. Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats
  16. Angiotensin II-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis
  17. (−)-Epigallocatechin gallate regulates dopamine transporter internalization via protein kinase C-dependent pathway
  18. Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons
  19. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-α and estrogen receptor-β in microglia
  20. Topiramate therapy for paroxysmal kinesigenic choreoathetosis
  21. (?)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury